Pfizer Reaches Settlement Deals With Drug Producers Dexcel Pharma, Hikma Pharmaceuticals, And Cipla Over Alleged Infringement Of VYNDAMAX To Extend Patent Expiry Through June 1, 2031
Pfizer Inc. (NYSE:PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the U.S. District
04/28/2026